Global Cell Separation Technologies Market Analysis: Technologies, Applications and Forecast to 2020, Published by iHealthcareAnalyst, Inc.

Cell Separation Technologies Market by Technology (Gradient Centrifugation, Separation based on Surface Markers, Fluorescence Activated Cell Sorting, Magnetic Activated Cell Sorting), and Application (Cancer Research, Immunology, Neuroscience Research, Stem Cell Research) 2016-2020

Maryland Heights, MO, January 26, 2017 --(PR.com)-- The global cell separation technologies market is estimated to reach USD 3.8 Billion in 2020, expanding at a CAGR of 10.6% from 2016 to 2020, due to higher demand for cell-based diagnostics and cell therapy applications. The wide array of cellular therapeutic medicine has influenced the cell separation technologies market. The cell separation technologies market is highly consolidated in nature with very few numbers of companies offering cell separation technologies worldwide. Separation based on surface markers contributed to the largest share of the global market, while by geography, North America dominated the overall global market closely followed by Europe.

Browse Cell Separation Technologies Market by Technology (Gradient Centrifugation, Separation based on Surface Markers, Fluorescence Activated Cell Sorting, Magnetic Activated Cell Sorting), and Application (Cancer Research, Immunology, Neuroscience Research, Stem Cell Research) 2016-2020 at https://www.ihealthcareanalyst.com/report/cell-separation-technologies-market/

The isolation of pure cell populations from a heterogeneous suspension is a fundamental aspect of clinical application and basic research. For the purpose of achieving high purity in stem cell separation, simplicity of the separation process and mass production of samples, new separation methods have been emerging in the field. Many cell separation techniques have been developed and are commercially available. Cell separation techniques can be broadly classified into two categories: techniques based on physical parameters (size/density), and techniques based on affinity (chemical, electrical, or magnetic couplings) The innovations in cell separation technologies brings new pathways of research in medical and therapeutics applications.

The global cell separation technologies market segmentation is based on technology (gradient centrifugation, separation based on surface markers, fluorescence activated cell sorting, magnetic activated cell sorting), and applications (cancer research, immunology, neuroscience research, stem cell research).

The global cell separation technologies market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020). The global cell separation technologies market research report is further segmented by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global cell separation technologies market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.

Major players operating in the global cell separation technologies market and included in this report are BD Bioscience, EMD Millipore, Mitenyi Biotec GmbH, and STEMCELL Technologies, Terumo BCT, pluriSelect GmbH, and Thermo Fisher Scientific, Inc.

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/cell-separation-technologies-market/

About Us
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: https://www.ihealthcareanalyst.com
Contact
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 500-7508
https://www.ihealthcareanalyst.com/
ContactContact
Categories